The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.
Melanoma and non-melanoma are two primary categories of skin cancer. Each presents different symptoms and treatment options. Within the non-melanoma skin cancer – sometimes referred to as NMSC – category, the two most common types…
Ships 21 systems with SRT-100 Vision™ systems sales continuing to rise Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., May 3, 2018 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device…
May 3, 2018 –Sensus Healthcare, Inc. has appointed Rita Gable as Vice President of Sales – Oncology. Ms. Gable, who will report to Joe Sardano, Sensus CEO, has 15 years of sales experience,…
New Addition to Senior Leadership Team Brings 15 Years of Marketing Experience to Supercharge Sensus’ Domestic Oncology Efforts BOCA RATON, Fla., May 1, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing…
Superficial Radio Therapy is the premier choice for physicians and patients when it comes to skin cancer treatment options. With the SRT-100 Vision for Skin Cancer Treatment, physicians and patients alike, are privileged to witness…
